Biotech

Biotech stocks live and die on single events. A drug clears the FDA and the stock doubles; a trial misses and it halves by morning. The Biotech view tracks those catalysts so you see them coming instead of reacting after the gap.

FDA catalysts and pipeline events, from approvals and recalls to upcoming decision dates.

What it tracks

• Approvals and rejections from the FDA, the events that reprice a name in seconds.
• PDUFA decision dates — the deadline by which the FDA must rule on a drug, so you can mark the calendar before the binary hits.
• Clinical trial phases and readouts, from early-stage data to the Phase 3 results that make or break a company.
• Recalls and warning letters, which cut the other way and can punish a stock fast.

These are binary movers. The whole position can turn on one announcement, which is exactly why knowing the dates in advance matters. A small-cap biotech with a PDUFA date next month is a very different stock the week before that ruling than the month before.

Each event carries SecBot's read on what it means for the company involved, so you don't need to parse trial endpoints or regulatory language to get the point. When something lands on a name you follow, you can see at a glance whether it's the kind of catalyst that moves the stock or routine pipeline housekeeping.

If you trade these setups, the FDA catalysts tutorial walks through how to read decision dates and position around them.

Related: trading FDA catalysts.